Preferred Name

Cilazapril Anhydrous

Synonyms
Definitions

The anhydrous form of the pyridazine angiotensin-converting enzyme (ACE) inhibitor cilazapril with antihypertensive activity. As a prodrug cilazapril is rapidly metabolized in the liver to cilazaprilat; cilazaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Cilazaprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.

ID

http://purl.obolibrary.org/obo/NCIT_C76134

CAS_Registry

88768-40-5

Chemical_Formula

C22H31N3O5

code

C76134

Contributing_Source

FDA

definition

The anhydrous form of the pyridazine angiotensin-converting enzyme (ACE) inhibitor cilazapril with antihypertensive activity. As a prodrug cilazapril is rapidly metabolized in the liver to cilazaprilat; cilazaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Cilazaprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.

FDA_UNII_Code

8Q9454114Q

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

label

Cilazapril Anhydrous

Legacy Concept Name

Cilazapril_Anhydrous

Preferred_Name

Cilazapril Anhydrous

prefixIRI

NCIT:C76134

prefLabel

Cilazapril Anhydrous

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0886706

subClassOf

http://purl.obolibrary.org/obo/NCIT_C247

Delete Subject Author Type Created
No notes to display